Novel 1-Methylquinazoline and 1-Methylquinoxaline derivatives targeting FtsZ protein: Potent antibacterial agents against gram-positive bacteria
Bioorganic Chemistry · 2025
DOI: 10.1016/j.bioorg.2025.109282 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von ShenYan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical S…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacterial Proteins, Quinoxalines, Cytoskeletal Proteins. Die Arbeit nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The continuous increase in bacterial resistance and the emergence of multi-drug resistant bacteria pose a great threat to the public healthcare industry. To address this challenge, we designed and synthesized a series of novel 1-methylquinazoline and 1-methylquinoxaline derivatives, which exhibited significant inhibitory activity against gram-positive bacteria. The bioactivity assay results showed that the dominant compounds, C1 and C9, were significantly better than the positive control drugs, linezolid and vancomycin, against typical gram-positive bacteria (Staphylococcus. Aureus ATCC 25923, MIC = 0.125 μg/mL; Bacilus. Subtilis ATCC 9372, MIC = 0.0625 μg/mL). Further studies revealed that C9 has the multiple advantages of low hemolytic toxicity, rapid bactericidal kinetic characteristics and low tendency to induce bacterial resistance. In vivo studies using a mouse model of bacteremia indicated that the therapeutic effect of C9 was comparable to that of linezolid. Mechanism studies confirmed that C9 interfereed with the normal division of bacteria by promoting the polymerization of FtsZ protein to inhibit the bacterial cell division, thus exerting highly effective antibacterial effects. The findings suggest that C9 is a promising candidate molecule that provides a new strategy to solve the problems posed by multidrug-resistant bacteria in the public healthcare industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 25001…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, S., Ding, H., Ma, Y., Kong, Y., Guo, T., Chen, W., Xue, J., Dong, J., & Ma, S. (2025). Novel 1-Methylquinazoline and 1-Methylquinoxaline derivatives targeting FtsZ protein: Potent antibacterial agents against gram-positive bacteria. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.109282
Vancouver
Zhang S, Ding H, Ma Y, Kong Y, Guo T, Chen W, et al. Novel 1-Methylquinazoline and 1-Methylquinoxaline derivatives targeting FtsZ protein: Potent antibacterial agents against gram-positive bacteria. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.109282
BibTeX
@article{Zhang2025,
author = {Zhang, ShenYan and Ding, Hang and Ma, Yangchun and Kong, Yue and Guo, Ting and Chen, Weijin and Xue, Jie and Dong, Jiale and Ma, Shutao},
title = {Novel 1-Methylquinazoline and 1-Methylquinoxaline derivatives targeting FtsZ protein: Potent antibacterial agents against gram-positive bacteria},
journal = {Bioorganic Chemistry},
year = {2025},
doi = {10.1016/j.bioorg.2025.109282}
}
EUVIMED